Table 4.
OneTouch UltraSoft | TheraSense FreeStyle | Ascensia Microlet / Vaculancec | ||||
---|---|---|---|---|---|---|
Scorea | p valueb | Scorea | p valueb | Scorea | p valueb | |
Accu-Chek Softclix | 0.60 ± 1.17 | n = 52<.001 | 0.52 ± 1.27 | n = 52.005 | 0.70 ± 1.41 | n = 52<.001 |
Accu-Chek Softclix Plus | 0.78 ± 1.06 | n = 78<.001 | 1.00 ± 1.12 | n = 78<.001 | 0.97 ± 1.14 | n = 78<.001 |
Accu-Chek Multiclix | 0.88 ± 1.27 | n = 78<.001 | 0.59 ± 1.26 | n = 78<.001 | 1.03 ± 1.16 | n = 78<.001 |
The subjects rated pairs of lancing devices (Accu-Chek versus competitor) on a NRS ranging from −3 (Accu-Chek less painful than competitor), over 0 (no difference between Accu-Chek and competitor), to +3 (Accu-Chek more painful than competitor). Data are means ± standard deviation. Data are from the 12-day and exit questionnaires.
Difference from 0.
Accu-Chek Softclix was compared to Ascensia Vaculance, and Accu-Chek Softclix Plus and Accu-Chek Multiclix were compared to Ascensia Microlet.